Shire plc (SHPG) Stock Analysis
DELISTED 2019
What happened to Shire plc (SHPG) stock?
Shire plc (SHPG) no longer trades on public markets. It was delisted in January 2019. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2019
- Last recorded price (historical):
- $179.20 (last quote on record before the January 2019 delisting; historical, not a current quote)
P/E 12.68 means the share price is 12.68 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Shire plc (SHPG). Shire plc, now part of Takeda Pharmaceutical Company Limited, was a global biotechnology leader focused on rare diseases. The company developed and marketed innovative therapies across neuroscience, hematology, immunology, and genetic diseases.
Last analyzed: Mar 16, 2026Shire plc (SHPG) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SHPG shares?
No. SHPG stopped trading on public markets in January 2019, so the shares are not available through a broker. Anything you see quoted for SHPG elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SHPG stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Shire plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.